M. Kudo graduated from Kyoto University. He received an M.D. degree in 1978. He received his Ph.D. degree in clinical science from Kyoto University Graduate School of Medicine in 1986. He serves currently a Professor and Chairman at the Department of Hepatology and Gastroenterology, Kinki University School of Medicine since 1999. Dr. Kudo is a pioneer of contrast-enhanced US for liver tumors; he published contrast-enhanced US during intra-arterial carbon dioxide (CO2) microbubbles in Radiology in 1991, 8 years before commercial-based ultrasound agent, Levovist, is available in routine clinical use. This is the first clinical report of contrast-enhanced US for liver tumors in the world. His main research interest is diagnosis and treatment of hepatocellular carcinoma. He published “Contrast-enhanced US in the diagnosis and treatment of liver tumors” from Springer-Verlag in 2003. He published 246 international scientific papers and 745 Japanese scientific papers. He also gave 142 invited lectures overseas so far. He is a Founding Member of the international liver cancer association (ILCA). He also served as an Associate Editor or Editorial Board Member of Ultrasound in Medicine and Biology, Hepatology Research, Journal of Gastroenterology, Liver International, and so on. He also served as a Guest Editor-in-Chief of Intervirology in 2003 and 2004, Oncology in 2007, and Digestive Disease in 2007. He is also serving as a journal referee of more than 30 peer-reviewed international journals. He is presently serving as an Executive Council Member of Japan Society of Hepatology (JSH) and Japan Society of Ultrasound in Medicine (JSUM), President-Elect of Asian Federation for Societies of Ultrasound in Medicine and Biology (AFSUMB), and Vice President of World Federation of Ultrasound in Medicine and Biology (WFUMB).
Biography Updated on 27 January 2011